Minerva Neurosciences | NERV - EPS Earnings Per Share


Minerva Neurosciences reported $-0.56 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Adma Biologics USD 0.19 0.01 Mar/2026
ALKERMES USD -0.4 0.69 Mar/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Cipla INR 6.86 8.34 Mar/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
CSL USD 5.07 3 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
Takeda JPY -15.56 81.3 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024